← Back to headlines

Novo Nordisk and Eli Lilly Fined for Drug Advertisements
The French drug safety agency ANSM has fined pharmaceutical companies Novo Nordisk and Eli Lilly for advertisements related to weight management drugs in France.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.


